Skip to content

$300,000 awarded to promote dementia awareness in diverse communities

By API User

Dementia Australia has today announced the recipients of the 2025 Diversity Small Grant program, awarding more than $300,000 to 10 Aboriginal, Torres Strait Islander and culturally and linguistically diverse community groups and organisations across Australia.  Each of the recipients were awarded up to $30,000 each to fund activities to build greater dementia awareness in their … Continued

‘Truly inspiring’: RACGP Aboriginal and Torres Strait Islander award winners announced

By API User

Winners of the Aboriginal and Torres Strait Islander Awards have been announced at the Royal Australian College of GPs (RACGP) annual conference in Brisbane.  Each year, Australia’s peak body for GPs honours GPs, GP Supervisors, GP registrars, students and practices that have distinguished themselves serving their communities through the College’s awards.   RACGP award winners are … Continued

RACGP award winners a ‘testament to rural and remote general practice care’

By API User

An esteemed group of rural GPs were recognised at the Royal Australian College of GPs’ (RACGP) recent annual conference in Brisbane.  Each year, Australia’s peak body for GPs honours GPs, registrars and practices that have distinguished themselves serving their communities through the state and national awards. This includes winners of the College’s rural awards.  RACGP … Continued

AdvanCell Appoints Philina Lee, PhD as Chief Executive Officer to Lead US Expansion and Drive Global Growth

By API User

Dr Lee is a seasoned biopharmaceutical executive with a proven track record of leading cross-functional teams to successfully develop and commercialize innovative therapies in oncology SYDNEY & BOSTON–BUSINESS WIRE– AdvanCell Pty Ltd (“AdvanCell”), a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Philina Lee, PhD as Chief Executive … Continued

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

By API User

ZIIHERAplus TEVIMBRA and chemotherapy demonstrated clinically meaningful and statistically significant improvements in PFS and OS versus trastuzumab and chemotherapy ZIIHERA plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first interim analysis … Continued

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

By API User

SHANGHAI & JERSEY CITY, N.J.–BUSINESS WIRE– Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) 420 mg/14 mL injection for intravenous use, an interchangeable biosimilar to PERJETA (pertuzumab), for all indications of the reference product.1 … Continued

ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline

By API User

At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane Lyft™, temple volume with investigational Restylane Contour™* and skin quality in the décolletage (neckline) with investigational Restylane Skinboosters™*1-3 Nine-month results from a first-of-its-kind clinical trial were presented, … Continued

Doctors For Nutrition Launches Australia’s First Publicly Available Culinary Medicine Course to Save Lives and Billions in Healthcare Costs

By API User

Australia’s healthcare system spends an estimated $10.4 billion annually treating diet-related chronic diseases such as cardiovascular disease, diabetes, and high blood pressure. These largely preventable conditions cause immense personal suffering and place relentless pressure on health services. Increasing fruit and vegetable consumption and adopting healthier eating patterns have the potential to reduce this disease burden … Continued

La Trobe scientists send ‘cell hotel’ on space mission

By API User

La Trobe University researchers have sent two 10-centimetre-high “cell hotels” on an international space mission to gain a better understanding of how the absence of gravity affects the human gut.  The small “hotel” cubes are miniature laboratories designed by La Trobe  researchers and Melbourne engineering firm Enable Aerospace. The cubes were among 21 international experiments on a sounding rocket launched by the German Aerospace Centre (DLR) from Sweden on 12 November.  La Trobe ran two mini labs on the shuttle, each filled with gut cells, affectionately nicknamed “Gastronauts”.  Professor Patrick Humbert, Director of the La Trobe … Continued

Monash Expert: From Resistance to Reform: New book presents analysis of policy areas where reform was achieved after many years of neglect

By API User

In his new book “From Resistance to Reform: Case studies of long term social justice advocacy in Australia,” Professor Philip Mendes, from the Department of Social Work presents a comprehensive historical and political analysis of four policy areas where reform was achieved after many years of neglect, including:   Young people transitioning from out-of-home care … Continued